ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,249,903 | +83.8% | 52,188 | +44.5% | 0.06% | +122.2% |
| Q1 2023 | $679,891 | -69.0% | 36,126 | -73.7% | 0.03% | -66.2% |
| Q4 2022 | $2,189,876 | -48.2% | 137,555 | -46.7% | 0.08% | -46.3% |
| Q3 2022 | $4,226,000 | +1610.9% | 258,297 | +1371.3% | 0.15% | +2028.6% |
| Q2 2022 | $247,000 | -60.3% | 17,556 | -34.1% | 0.01% | -70.8% |
| Q4 2021 | $622,000 | +67.2% | 26,637 | +18.8% | 0.02% | +71.4% |
| Q3 2021 | $372,000 | -91.1% | 22,426 | -86.1% | 0.01% | -89.2% |
| Q1 2021 | $4,177,000 | +21.8% | 161,892 | +152.4% | 0.13% | +14.0% |
| Q4 2020 | $3,429,000 | – | 64,134 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |